List of insiders holdings for Gain Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Islam Khalid Executive Chairman | 2024-08-12 17:23:30 | 50,000 880,784 | 930,784 | Form 4 |
| RICHMAN ERIC I Director | 2024-07-01 17:00:27 | 289,629 14,829 | 304,458 | Form 4 |
| Ballantyne Charles Evan Chief Financial Officer | 2023-04-12 17:36:02 | 150,000 0 | 150,000 | Form 4 |
| Bellotto Manolo President and General Manager | 2021-03-29 20:38:38 | 123,309 0 | 123,309 | Form 3 |
| Alder Matthias Chief Executive Officer | 2024-03-28 21:00:08 | 92,016 0 | 92,016 | Form 4 |
| Calabrese Salvatore Chief Financial Officer | 2023-03-27 17:28:43 | 75,000 0 | 75,000 | Form 4 |
| Fuggetta Gianluca See Remark | 2024-03-25 21:30:15 | 50,000 0 | 50,000 | Form 4 |
| Riley Jeffrey Scott Director | 2024-06-26 21:30:06 | 15,000 0 | 15,000 | Form 4 |
| GOLDSTEIN DOV A MD Director | 2024-06-26 21:30:07 | 15,000 0 | 15,000 | Form 4 |
| Nicaise Claude Director | 2024-06-26 21:30:08 | 15,000 0 | 15,000 | Form 4 |
| HASLER HANS PETER Director | 2024-06-26 21:30:09 | 15,000 0 | 15,000 | Form 4 |
| Melincoff Gwen A Director | 2024-06-26 21:30:11 | 15,000 0 | 15,000 | Form 4 |
| Mack Gene CFO and Interim CEO | 2024-08-12 17:23:31 | 14,400 0 | 14,400 | Form 4 |